| Bioactivity | Fasoracetam (NS 105) is the activator of metabotropic glutamate receptor (mGluR). Fasoracetam (NS 105) has the potential for the research of attention-deficit hyperactivity disorder (ADHD) and Alzheimer's disease (AD)[1][2]. | ||||||||||||
| Target | mGluR | ||||||||||||
| Name | Fasoracetam | ||||||||||||
| CAS | 110958-19-5 | ||||||||||||
| Formula | C10H16N2O2 | ||||||||||||
| Molar Mass | 196.25 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Elia J, et al. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. Nat Commun. 2018;9(1):4. |
Fasoracetam
CAS: 110958-19-5 F: C10H16N2O2 W: 196.25
Fasoracetam (NS 105) is the activator of metabotropic glutamate receptor (mGluR). Fasoracetam (NS 105) has the potential
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.